$HSTM
HEALTHSTREAM INC

2024 Q4 Form 10-Q Financial Statement

#000143774924032036 Filed on October 24, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $73.10M
YoY Change 3.92%
Cost Of Revenue $24.47M
YoY Change 3.73%
Gross Profit $48.63M
YoY Change 4.01%
Gross Profit Margin 66.52%
Selling, General & Admin $19.95M
YoY Change 13.44%
% of Gross Profit 41.04%
Research & Development $12.10M
YoY Change 11.0%
% of Gross Profit 24.88%
Depreciation & Amortization $10.07M
YoY Change -3.17%
% of Gross Profit 20.72%
Operating Expenses $12.10M
YoY Change 11.0%
Operating Profit $6.498M
YoY Change 33.62%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $981.0K
YoY Change 66.27%
Pretax Income $7.479M
YoY Change 37.15%
Income Tax $1.800M
% Of Pretax Income 24.07%
Net Earnings $5.725M
YoY Change 48.05%
Net Earnings / Revenue 7.83%
Basic Earnings Per Share $0.19
Diluted Earnings Per Share $0.19
COMMON SHARES
Basic Shares Outstanding 30.41M 30.41M
Diluted Shares Outstanding 30.59M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.89M
YoY Change 32.14%
Cash & Equivalents $57.49M
Short-Term Investments $37.40M
Other Short-Term Assets $3.163M
YoY Change -66.72%
Inventory
Prepaid Expenses
Receivables $26.33M
Other Receivables $0.00
Total Short-Term Assets $145.6M
YoY Change 14.79%
LONG-TERM ASSETS
Property, Plant & Equipment $11.09M
YoY Change -18.1%
Goodwill $191.1M
YoY Change 0.05%
Intangibles
YoY Change
Long-Term Investments $3.984M
YoY Change -5.14%
Other Assets $584.0K
YoY Change 23.73%
Total Long-Term Assets $357.2M
YoY Change -3.77%
TOTAL ASSETS
Total Short-Term Assets $145.6M
Total Long-Term Assets $357.2M
Total Assets $502.8M
YoY Change 0.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.444M
YoY Change 26.29%
Accrued Expenses $17.37M
YoY Change -17.22%
Deferred Revenue $82.94M
YoY Change -0.34%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $110.6M
YoY Change -3.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $1.986M
YoY Change -7.28%
Total Long-Term Liabilities $1.986M
YoY Change -7.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $110.6M
Total Long-Term Liabilities $1.986M
Total Liabilities $112.6M
YoY Change -3.57%
SHAREHOLDERS EQUITY
Retained Earnings $104.9M
YoY Change 18.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $355.5M
YoY Change
Total Liabilities & Shareholders Equity $502.8M
YoY Change 0.96%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $5.725M
YoY Change 48.05%
Depreciation, Depletion And Amortization $10.07M
YoY Change -3.17%
Cash From Operating Activities $19.11M
YoY Change -22.53%
INVESTING ACTIVITIES
Capital Expenditures $6.839M
YoY Change 1.77%
Acquisitions
YoY Change
Other Investing Activities -$31.00K
YoY Change -101.11%
Cash From Investing Activities -$6.870M
YoY Change 75.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -922.0K
YoY Change -62.21%
NET CHANGE
Cash From Operating Activities 19.11M
Cash From Investing Activities -6.870M
Cash From Financing Activities -922.0K
Net Change In Cash 11.32M
YoY Change -38.18%
FREE CASH FLOW
Cash From Operating Activities $19.11M
Capital Expenditures $6.839M
Free Cash Flow $12.27M
YoY Change -31.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
949000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
781000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22362000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19503000 usd
CY2024Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
144894000 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
127009000 usd
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30415000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30415000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30298000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30298000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.028
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.028
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.028
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.025
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.025
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.025
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-27701
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1443555
dei Entity Address Address Line1
EntityAddressAddressLine1
500 11th Avenue North, Suite 1000
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37203
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
301-3100
dei Security12b Title
Security12bTitle
Common Stock (Par Value $0.00)
dei Trading Symbol
TradingSymbol
HSTM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30414883
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57489000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40333000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
37404000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
30800000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26326000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
34346000 usd
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
5350000 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
4100000 usd
CY2024Q3 us-gaap Prepaid Royalties
PrepaidRoyalties
9239000 usd
CY2023Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
10202000 usd
CY2024Q3 hstm Prepaid Software Maintenance And Subscriptions
PrepaidSoftwareMaintenanceAndSubscriptions
6677000 usd
CY2023Q4 hstm Prepaid Software Maintenance And Subscriptions
PrepaidSoftwareMaintenanceAndSubscriptions
7397000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3163000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3032000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
145648000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
130210000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11086000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13005000 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
42472000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
40643000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18172000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20114000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
191139000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
191379000 usd
CY2024Q3 hstm Contract With Customer Asset Sales Commission Noncurrent
ContractWithCustomerAssetSalesCommissionNoncurrent
31777000 usd
CY2023Q4 hstm Contract With Customer Asset Sales Commission Noncurrent
ContractWithCustomerAssetSalesCommissionNoncurrent
31700000 usd
CY2024Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3984000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
4134000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
584000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
726000 usd
CY2024Q3 us-gaap Assets
Assets
502831000 usd
CY2023Q4 us-gaap Assets
Assets
499942000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4444000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7465000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17367000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22717000 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5822000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
4556000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
82939000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
83623000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
110572000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
118361000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15177000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16132000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1671000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2169000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17944000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20247000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1986000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2281000 usd
CY2024Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
251428000 usd
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
249075000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
104937000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
92368000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-884000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-691000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
355481000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
340752000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
502831000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
499942000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73095000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70339000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217411000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208482000 usd
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
24470000 usd
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
23587000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
72825000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
71010000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12100000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10901000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36208000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33610000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11497000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11290000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34676000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34324000 usd
CY2024Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8457000 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
9295000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
26325000 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
27223000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10073000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10403000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30779000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30550000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
66597000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
65476000 usd
us-gaap Costs And Expenses
CostsAndExpenses
200813000 usd
us-gaap Costs And Expenses
CostsAndExpenses
196717000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6498000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4863000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
16598000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
11765000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
981000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
590000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2722000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1329000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7479000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5453000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19320000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13094000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1754000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1586000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4202000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2471000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
5725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3867000 usd
us-gaap Net Income Loss
NetIncomeLoss
15118000 usd
us-gaap Net Income Loss
NetIncomeLoss
10623000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.5
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30409000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30683000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30374000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30653000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30590000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30769000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30512000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30734000
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.028
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.025
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.084
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.075
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
5725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3867000 usd
us-gaap Net Income Loss
NetIncomeLoss
15118000 usd
us-gaap Net Income Loss
NetIncomeLoss
10623000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
290000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-371000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-229000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-227000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
43000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
21000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
36000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-31000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
333000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-350000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-193000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-258000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6058000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3517000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14925000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10365000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
340752000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5227000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-481000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
849000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1060000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
855000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
344854000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
4168000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45000 usd
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
851000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1094000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
349214000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
5725000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
333000 usd
CY2024Q3 us-gaap Dividends Common Stock
DividendsCommonStock
851000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1131000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
71000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
355481000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
334064000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2623000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-35000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
767000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
945000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
791000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
336039000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
4133000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
127000 usd
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
767000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1093000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
340619000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3867000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-350000 usd
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
767000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1038000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2141000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
342246000 usd
us-gaap Net Income Loss
NetIncomeLoss
15118000 usd
us-gaap Net Income Loss
NetIncomeLoss
10623000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30779000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30550000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3285000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3076000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
9060000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
8467000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2027000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
675000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-960000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2634000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-150000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-330000 usd
hstm Change In Fair Value Of Non Marketable Equity Investments
ChangeInFairValueOfNonMarketableEquityInvestments
0 usd
hstm Change In Fair Value Of Non Marketable Equity Investments
ChangeInFairValueOfNonMarketableEquityInvestments
-45000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1205000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
603000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4744000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7230000 usd
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-962000 usd
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
1684000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
177000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
817000 usd
hstm Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
9138000 usd
hstm Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
9583000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-143000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-336000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8371000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-736000 usd
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
1266000 usd
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
1419000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1183000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3554000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50158000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6621000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
46170000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
51531000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
38235000 usd
hstm Proceeds From The Sale Of Nonmarketable Equity Investments
ProceedsFromTheSaleOfNonmarketableEquityInvestments
765000 usd
hstm Proceeds From The Sale Of Nonmarketable Equity Investments
ProceedsFromTheSaleOfNonmarketableEquityInvestments
45000 usd
us-gaap Payments For Software
PaymentsForSoftware
20107000 usd
us-gaap Payments For Software
PaymentsForSoftware
19552000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1198000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1854000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25901000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47217000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
932000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
817000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1648000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2551000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2301000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3483000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4766000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-75000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17156000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1900000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40333000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46023000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57489000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44123000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73095000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
70339000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217411000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208482000 usd
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
300000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
700000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
45000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
42200000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
79400000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
76000000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
549000000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.43 pure
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
3100000 usd
CY2023Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
3000000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
9100000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
8500000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1800000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2500000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 pure
hstm Income Tax Expense Benefit Discrete Adjustments
IncomeTaxExpenseBenefitDiscreteAdjustments
100000 usd
hstm Reserve For Uncertain Tax Position
ReserveForUncertainTaxPosition
200000 usd
hstm Income Tax Expense Benefit Stockbased Awards
IncomeTaxExpenseBenefitStockbasedAwards
-100000 usd
hstm Income Tax Expense Benefit Discrete Adjustments
IncomeTaxExpenseBenefitDiscreteAdjustments
-100000 usd
hstm Income Tax Expense Benefit State Appointment Change
IncomeTaxExpenseBenefitStateAppointmentChange
-600000 usd
hstm Income Tax Expense Benefit Stockbased Awards
IncomeTaxExpenseBenefitStockbasedAwards
-100000 usd
hstm Reserve For Uncertain Tax Position
ReserveForUncertainTaxPosition
300000 usd
hstm Income Tax Expense Benefit Merger
IncomeTaxExpenseBenefitMerger
300000 usd
CY2024Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.084
us-gaap Dividends Cash
DividendsCash
2551000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1131000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1038000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3285000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3076000 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
177000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
340000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
278000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
5725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3867000 usd
us-gaap Net Income Loss
NetIncomeLoss
15118000 usd
us-gaap Net Income Loss
NetIncomeLoss
10623000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30409000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30683000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30374000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30653000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
181000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
86000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
138000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
81000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30590000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30769000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30512000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30734000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.5
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
37357000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
48000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
37404000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
30791000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
30800000 usd

Files In Submission

Name View Source Status
0001437749-24-032036-index-headers.html Edgar Link pending
0001437749-24-032036-index.html Edgar Link pending
0001437749-24-032036.txt Edgar Link pending
0001437749-24-032036-xbrl.zip Edgar Link pending
ex_712050.htm Edgar Link pending
ex_712051.htm Edgar Link pending
ex_712052.htm Edgar Link pending
ex_712053.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstm-20240930.xsd Edgar Link pending
hstm-20240930_def.xml Edgar Link unprocessable
hstm-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hstm-20240930_cal.xml Edgar Link unprocessable
hstm20240930_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hstm20240930_10q_htm.xml Edgar Link completed
hstm-20240930_pre.xml Edgar Link unprocessable